Splice-switching ASOs targeting an Alu-derived exon in the AURKA 5'UTR collapse an SRSF1-AURKA-MYC oncogenic circuit in pancreatic cancer
Kral, A. J.; Jia, L.; Sim, G.; Wan, L.; Krainer, A. R.
Show abstract
Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal malignancy, driven by oncogenic KRAS mutations and dysregulated oncogenes, such as SRSF1, MYC, and AURKA. Although KRAS-targeted therapies are in development, resistance mechanisms underscore the need to identify alternative vulnerabilities. Here, we uncover an SRSF1-AURKA-MYC oncogenic circuit, wherein SRSF1 regulates AURKA 5UTR alternative splicing, enhancing AURKA protein expression; AURKA positively regulates SRSF1 and MYC post-translationally, independently of its kinase activity; and MYC in turn transcriptionally upregulates both SRSF1 and AURKA. Elevated SRSF1 in tumor cells promotes inclusion of an exonized Alu exon in the AURKA 5UTR, resulting in splicing-dependent mRNA accumulation and exon-junction- complex deposition. Modulating 5UTR splicing with splice-switching antisense oligonucleotides (ASOs) collapses the oncogenic circuit, reducing PDAC cell viability and triggering apoptosis. Our findings identify AURKA alternative splicing as a critical regulatory node and highlight ASO-mediated splice-switching as a potential therapeutic strategy that simultaneously targets SRSF1, AURKA, and MYC oncogenes.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- An integrative oncogene-dependency map identifies unique vulnerabilities of oncogenic EGFR, KRAS, and RIT1 in lung cancer 96%
- The pan-cancer lncRNA PLANE regulates an alternative splicing program to promote cancer pathogenesis 96%
- The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma. 96%
Similar papers in this journal
- Generation of a biliary tract cancer cell line atlas reveals molecular subtypes and therapeutic targets 94%
- Paradoxical activation of oncogenic signaling as a cancer treatment strategy 94%
- Increased RNA and protein degradation is required for counteracting transcriptional burden and proteotoxic stress in human aneuploid cells 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.